Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the nidus of Aβ plaques develops from within neurites at a time course that could also fit that of plaque formation determined by multiphoton microscopy (MPM) occurring within a day [120].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the AD brain, microglia accumulate at the site of newly formed A deposits via migration or local proliferation and may help restrict plaque growth.4,5”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brains of AD patients and APP-overexpressing mice, plaques are surrounded by reactive microglia and astrocytes (Meyer-Luehmann et al., 2008; Serrano-Pozo et al., 2013)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Meyer-Luehmann et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia appear rapidly (within one day) at the site of newly formed plaques [78].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“Remarkably, this MPM study of AD transgenic mouse brain in vivo also described the emergence of dystrophic neurites in areas distant from plaques that appeared and, at times, even disappeared, although intraneuronal Aβ was not examined in these neurites.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 2×
“These data thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid deposition, activation and recruitment of microglia and local neuritic changes play out as a sequential cascade leading to neurodegeneration 1 .”
BackgroundResultWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“To examine whether the phenotype of plaque formation in as short a period as one week was unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a slower progression of disease (Tg2576) 7 .”
BackgroundMethodImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In addition, homozygous PDAPP mice 16 were crossed with homozygous CX3CR1-GFP mice 17 , and two female PDAPP +/ − ×CX3CR1-GFP +/ − transgenic mice at the age of 18 months were used in this study and imaged for three consecutive days.”
BackgroundMethodJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 1×
“These results are surprising because it has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process 22 .”
ResultJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“It has been proposed that activated microglia clear amyloid deposits 13 , are the nidus for initiation of amyloid fibrils 14 or restrict plaques 15 .”
Background
Cited by
Items 401–500 of 995
Scott, L. L., & Downing, T. G. (2017) · Toxins · doi:10.3390/toxins10010022 · Cited by 63
“[116] reported that microglial cells are typically recruited to plaques within 1–2 days of their appearance, but while microglial cells possess the ability to take up fibrillar forms of β-amyloid it seems as though the microglia have a difficult time degrading these dense aggregates in the AD brain and as a result do…”
BackgroundMicroglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading
Aires, I. D., Ribeiro‐Rodrigues, T., Boia, R., Ferreira-Rodrigues, M., Girão, H., Ambrósio, A. F., & Santiago, A. R. (2021) · Biomolecules · doi:10.3390/biom11060770 · Cited by 61
“The demonstration that microglia rapidly migrate toward new plaques [13,14] engulfing Aβ [14,15] suggests that activated microglia may be protective to some extent in the setting of Aβ pathology [9,13–15].”
BackgroundIntracellular calcium signalling in Alzheimer’s disease
Hermes, M., Eichhoff, G., & Garaschuk, O. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00976.x · Cited by 56
Stable Size Distribution of Amyloid Plaques Over the Course of Alzheimer Disease
Serrano-Pozo, A., Mielke, M. L., Muzitansky, A., Gómez-Isla, T., Growdon, J. H., Bacskai, B. J., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825e77de · Cited by 56
“Early studies described a rapid appearance of plaques and little, if any, growth of plaques after formation (8, 9); however, more recent studies with longer follow-up have reported a gradual or even a more dramatic growth of newly formed plaques over weeks to months but not of preexisting plaques (10Y13).”
Self-citationDubal, D. B., Broestl, L., & Worden, K. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-24 · Cited by 55
“These human observations, combined with evidence from transgenic mouse models of AD, also support the concept that plaques and neurofibrillary tangles, though potentially toxic in their own right [18-20], may not be the primary or driving cause of cognitive dysfunction.”
BackgroundHao, W., Liu, Y., Liu, S., Walter, S., Grimm, M. O., Kiliaan, A. J., Penke, B., Hartmann, T., Rübe, C. E., Menger, M. D., et al. (2011) · Brain · doi:10.1093/brain/awq325 · Cited by 56
“…of microglia can be visualized around Ab deposits even before neuronal damage occurs (Benzing et al., 1999; McGowan et al., 1999; Bolmont et al., 2008; Meyer-Luehmann et al., 2008), further arguing for a role of neu- roinflammation in progressive neurodegeneration in Alzheimer’s disease.”
Backgroundα-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells
Wilkaniec, A., Strosznajder, J. B., & Adamczyk, A. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.08.004 · Cited by 65
Exercise-Induced Modulation of Neuroinflammation in Models of Alzheimer’s Disease
Kelly, Á. M. (2018) · Brain Plasticity · doi:10.3233/bpl-180074 · Cited by 55
“The use of in vivo multiphoton microscopy has demonstrated that when plaques begin to form in APP/PS-1 mice, microglial cells begin to aggregate around them within one to two days and that this aggregation is followed by dysmorphic changes in neurites [105].”
BackgroundRegulation of Caspases in the Nervous System
Troy, C. M., Akpan, N., & Jean, Y. Y. (2011) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385504-6.00007-5 · Cited by 55
NSAIDs: how they work and their prospects as therapeutics in Alzheimer's disease
Sastre, M., & Gentleman, S. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00020 · Cited by 68
“In addition, a paper of Meyer-Luehmann et al. (2008) using two-photon microscopy showed that microglia in the aged mouse brain is less motile and posses fewer processes.”
Wan, W., Cao, L., Liu, L., Kalionis, B., Chen, C., Tai, X., Li, Y., & Xia, S.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113126 · Cited by 58
“Extracellular deposition of the amyloid beta (Ab) is widely accepted as an important event in the pathogenesis of AD [10,11].”
BackgroundAlzheimer’s disease: An update of the roles of receptors, astrocytes and primary cilia (Review)
ARMATO, U., CHAKRAVARTHY, B., PACCHIANA, R., & WHITFIELD, J. F. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1162 · Cited by 55
Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids
Gualtierotti, R., Guarnaccia, L., Beretta, M., Navone, S. E., Campanella, R., Riboni, L., Rampini, P. M., & Marfia, G. (2017) · Advances in Therapy · doi:10.1007/s12325-016-0474-7 · Cited by 62
Presenilin/γ-Secretase Activity Is Located in Acidic Compartments of Live Neurons
Maesako, M., Houser, M. C. Q., Turchyna, Y., Wolfe, M. S., & Berezovska, O. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1698-21.2021 · Cited by 55
Huttunen, H. J., Havas, D., Peach, C., Barren, C., Duller, S., Xia, W., Frosch, M. P., Hutter-Paier, B., Windisch, M., & Kovacs, D. M. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e77ed9 · Cited by 54
Gao, Y., Liu, Q., Xu, L., Zheng, N., Xiao-ming, H., & Xu, F. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00393-6 · Cited by 56
“Longitudinal imaging has shown that amyloid plaques develop surprisingly rapidly and microglia become reactive and are attracted to the sites of plaque formation within 24 h [15].”
BackgroundCarranza-Naval, M. J., del Marco, A., Hierro-Bujalance, C., Alves-Martinez, P., Infante-Garcia, C., Vargas-Soria, M., Herrera, M., Barba-Cordoba, B., Atienza-Navarro, I., Lubian-Lopez, S., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.741923 · Cited by 54
Ding, M., Ding, S., Du, D., Wang, X., Hu, X., Guan, P., Lyu, Z., & Lin, Y. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117087 · Cited by 59
Monocytes and Alzheimer’s disease
Feng, Y., Li, L., & Sun, X. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1205-3 · Cited by 62
Liu, W., Cai, H., Lin, M., Zhu, L., Gao, L., Zhong, R., Bi, S., Xue, Y., & Shang, X. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.026 · Cited by 58
Harwell, C. S., & Coleman, M. P. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0110-7 · Cited by 54
“While outer cortical layers of FAD mouse brain can be imaged using a cranial window [18, 19], key areas of pathology such as the hippocampus cannot.”
Murakami, K. (2014) · Bioscience, Biotechnology, and Biochemistry · doi:10.1080/09168451.2014.940275 · Cited by 53
Liu, Y., Zhuang, D., Wang, J., Huang, H., Li, R., Wu, C., Deng, Y., Hu, G., & Guo, B. (2022) · The Analyst · doi:10.1039/d2an01327d · Cited by 54
Systems biology of neurodegenerative diseases
Wood, L. B., Winslow, A. R., & Strasser, S. D. (2015) · Integrative Biology · doi:10.1039/c5ib00031a · Cited by 53
Imaging of Leukocyte Trafficking in Alzheimer’s Disease
Pietronigro, E., Zenaro, E., & Constantin, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00033 · Cited by 53
“The rapid appearance of new amyloid plaques induces progressive changes in neurites, manifesting as dendritic and axonal abnormalities, and the activation and recruitment of microglia to areas with amyloid plaques (63).”
BackgroundA quadrupolar two-photon fluorescent probe for in vivo imaging of amyloid-β plaques
Heo, C. H., Sarkar, A. R., Baik, S. H., Jung, T. S., Kim, J. J., Kang, H., Mook‐Jung, I., & Kim, H. M. (2016) · Chemical Science · doi:10.1039/c6sc00355a · Cited by 57
Zhang, W., Bai, M., Ye, X., Hao, J., Zhang, Z., Su, C., Lei, G., Miao, J., & Li, Z. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.023 · Cited by 54
“, 2004), APPswe/PS1d9xYFP mice (Meyer-Luehmann et al., 2008), 3 Tg-AD mice (Rodríguez et al.”
RetractedAltered motility of plaque-associated microglia in a model of Alzheimer’s disease
Gyoneva, S., Swanger, S. A., Zhang, J., Weinshenker, D., & Traynelis, S. F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.061 · Cited by 52
“Methoxy-X04 has been extensively used to study microglial dynamics in AD models and does not appear to affect the motility of microglia not associated with plaques (Bolmont et al., 2008; Koeningsknecht-Talboo et al., 2008; Klunk et al., 2002; Krabbe et al., 2013; Meyer-Luehmann et al., 2008).”
BackgroundInfante‐Garcia, C., Ramos‐Rodríguez, J. J., Delgado-Olmos, I., Gamero-Carrasco, C., Fernández-Ponce, M. T., Casas, L., Mantell, C., & García-Alloza, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0015-z · Cited by 57
“Neurite curvature was increased in the proximity of SP, and a “halo” effect was detected as distance to plaques increased, as previously described [27].”
ResultVadukul, D. M., Maina, M., Franklin, H., Nardecchia, A., Serpell, L. C., & Marshall, K. E. (2020) · FEBS Letters · doi:10.1002/1873-3468.13919 · Cited by 52
Krell‐Roesch, J., Rakuša, M., Syrjanen, J. A., van Harten, A. C., Lowe, V. J., Jack, C. R., Kremers, W. K., Knopman, D. S., Stokin, G. B., Petersen, R. C., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12557 · Cited by 57
Cellular Prion Protein as a Therapeutic Target in Alzheimer's Disease
Laurén, J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130950 · Cited by 51
Fibrillar and Nonfibrillar Amyloid Beta Structures Drive Two Modes of Membrane-Mediated Toxicity
Zanden, C. M. V., Wampler, L., Bowers, I., Watkins, E. B., Majewski, J. P., & Chi, E. Y. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b02484 · Cited by 52
Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews
Majidazar, R., Rezazadeh‐Gavgani, E., Sadigh‐Eteghad, S., & Naseri, A. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03363-6 · Cited by 55
“Amyloid plaques are characteristics of this theory, and many trials have been designed to evaluate the effects of various agents on amyloid cascade and AD pathogenesis [78, 79].”
BackgroundPlá, V., Paco, S., Ghezali, G., Ciria, V., Pozas, E., Ferrer, I., & Aguado, F. (2013) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00644.x · Cited by 50
“Recent in vivo observations, showing that amyloid deposition precedes neuritic pathology in APPswe/PS1dE9 mice, support a mediation of plaque-associated Ab changing secretory sorting receptors in AD (30).”
BackgroundMultiphoton in vivo imaging of amyloid in animal models of Alzheimer’s disease
Dong, J., Revilla-Sanchez, R., Moss, S., & Haydon, P. G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.007 · Cited by 50
“…in a transgenic model of AD (Spires et al., 2005) or by crossing a transgenic model of AD with another mouse lines containing fluorescent reporter (Tsai et al., 2004; Meyer-Luehmann et al., 2008; Bolmont et al., 2008), it is possible to image dendrites and spines as well as microglia and plaques.”
BackgroundInfluentialEMMPRIN, an upstream regulator of MMPs, in CNS biology
Kaushik, D. K., Hahn, J. N., & Yong, V. W. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.018 · Cited by 55
Calcium imaging in the living brain: prospects for molecular medicine
Rochefort, N. L., Jia, H., & Konnerth, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.07.005 · Cited by 65
ZHANG, B., WANG, A., XIA, C., LIN, Q., & CHEN, C. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3968 · Cited by 50
Choi, J., Gao, J., Kim, J., Hong, C., Kim, J., & Tontonoz, P. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad1904 · Cited by 56
Effect of disturbances in neuronal calcium and IP3 dynamics on β-amyloid production and degradation
Pawar, A., & Pardasani, K. R. (2022) · Cognitive Neurodynamics · doi:10.1007/s11571-022-09815-0 · Cited by 55
“The neuron cell undergoes degenerative changes with Ab accumulation in APP mutant mice, referring the Ab neurotoxicity due to involvement of calcium (Meyer-Luehmann et al. 2008).”
BackgroundDoustar, J., Rentsendorj, A., Torbati, T., Regis, G. C., Fuchs, D.-T. S., Sheyn, J., Mirzaei, N., Graham, S. L., Shah, P. K., Mastali, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13246 · Cited by 48
“…and behavioral changes include vast parenchymal and vascular Aβ accumulation, both in its soluble and insoluble forms, astrocytic, microglial, and molecular inflammatory responses, in addition to synaptic loss and subsequent cognitive decline (Jankowsky et al., 2004; Meyer-Luehmann et al., 2008).”
BackgroundLutter, L., Serpell, C. J., Tuite, M. F., & Xue, W. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.07.010 · Cited by 53
Berthelot, K., Ta, H. P., Géan, J., Lecomte, S., & Cullin, C. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.07.009 · Cited by 53
Zhang, L., Trushin, S., Christensen, T. A., Tripathi, U., Hong, C. C., Geroux, R. E., Howell, K. G., Poduslo, J. F., & Trushina, E. V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.003 · Cited by 59
Montinaro, M., Uberti, D. L., Maccarinelli, G., Bonini, S. A., Ferrari‐Toninelli, G., & Memo, M. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.008 · Cited by 48
“Therefore, a reduction in the oxidative damage might be a key player in the modulation of the immune system and both these events act simultaneously to counteract Aβ accumulation and deposition (Dudal et al., 2004; Meyer-Luehmann et al., 2008; Zhang et al., 2012).”
BackgroundImpaired astrocytic Ca2+ signaling in awake-behaving Alzheimer’s disease transgenic mice
Åbjørsbråten, K. S., Skaaraas, G. H. E. S., Cunen, C., Bjørnstad, D. M., Binder, K. M. G., Bojarskaite, L., Jensen, V., Nilsson, L. N. G., Rao, S. B., Tang, W., et al. (2022) · eLife · doi:10.7554/elife.75055 · Cited by 53
Ramos-Rodriguez, J. J., Molina-Gil, S., Rey-Brea, R., Berrocoso, E., & Garcia-Alloza, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079947 · Cited by 46
“order to study the relationship between these alterations, most of the studies have focused on the effect of Ab and tau pathology on neuronal morphology and function [2,3,5,28], however approach-”
BackgroundIn Vivo Imaging of Microglia With Multiphoton Microscopy
Hierro-Bujalance, C., Bacskai, B. J., & Garcia-Alloza, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00218 · Cited by 46
“It was also implied that microglia do not successfully clear plaques, unless further activated, suggesting that they restrict senile plaque growth instead, and contribute to the steady state of plaque size after initial formation (Meyer-Luehmann et al., 2008).”
BackgroundSelf-citationMichno, W., Stringer, K. M., Enzlein, T., Passarelli, M. K., Escrig, S., Vitanova, K. S., Wood, J. I., Blennow, K., Zetterberg, H., Meibom, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg4855 · Cited by 54
A qualitative model for aggregation and diffusion of $$\beta $$ -amyloid in Alzheimer’s disease
Achdou, Y., Franchi, B., Marcello, N., & Tesi, M. C. (2012) · Journal of Mathematical Biology · doi:10.1007/s00285-012-0591-0 · Cited by 60
“Since the fibrils at this stage are relatively small, diffusion also plays a key role in the description of the behaviours of the fibrils, as recently discussed e.g. in MeyerLuhmann (2004); Meyer-Luehmann et al. (2008).”
BackgroundMethodResultInfluentialIKKβ Deficiency in Myeloid Cells Ameliorates Alzheimer's Disease-Related Symptoms and Pathology
Liu, Y., Liu, X., Hao, W., Decker, Y., Schomburg, R., Fülöp, L., Pasparakis, M., Menger, M. D., & Fassbender, K. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1348-14.2014 · Cited by 46
“In AD mouse models, which overexpress Alzheimer’s APP in neurons, microglia are observed to be activated and recruited to deposits of pathogenic amyloid peptides (A ) (Bolmont et al., 2008; Meyer-Luehmann et al., 2008).”
BackgroundUltra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs
Espargaró, A., Medina, A., Pietro, O. D., Muñoz‐Torrero, D., & Sabaté, R. (2016) · Scientific Reports · doi:10.1038/srep23349 · Cited by 50
Xiao, Y. M., Dai, Y., Li, L., Geng, F., Xu, Y., Wang, J., Wang, S., & Zhao, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111651 · Cited by 46
NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load
Pohlkamp, T., Xian, X., Wong, C. H., Durakoglugil, M. S., Werthmann, G. C., Saido, T. C., Evers, B. M., White, C. L., Connor, J., Hammer, R. E., et al. (2021) · eLife · doi:10.7554/elife.72034 · Cited by 46
Meilandt, W. J., Maloney, J. A., Imperio, J., Lalehzadeh, G., Earr, T., Crowell, S., Bainbridge, T. W., Lu, Y., Ernst, J. A., Fuji, R. N., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0553-5 · Cited by 45
Simulation of disturbances in interdependent calcium and β-amyloid dynamics in the nerve cell
Pawar, A., & Pardasani, K. R. (2022) · The European Physical Journal Plus · doi:10.1140/epjp/s13360-022-03164-x · Cited by 46
“The neurons experience degenerative changes with β -amyloid assemblage in APP mutant mice, implying the A β neurotoxicity is driven by the association of [Ca 2+ ] [48].”
BackgroundAmyloid Plaques of Alzheimer’s Disease as Hotspots of Glutamatergic Activity
Ovsepian, S. V., O’Leary, V. B., Záborszky, L., Ntziachristos, V., & Dolly, J. O. (2018) · The Neuroscientist · doi:10.1177/1073858418791128 · Cited by 47
Long-term dynamics of aberrant neuronal activity in awake Alzheimer’s disease transgenic mice
Korzhova, V., Marinković, P., Njavro, J. R., Goltstein, P. M., Sun, F., Tahirović, S., Herms, J. W., & Liebscher, S. (2021) · Communications Biology · doi:10.1038/s42003-021-02884-7 · Cited by 54
Structural (dys)connectivity associates with cholinergic cell density in Alzheimer’s disease
Lin, C., Frigerio, I., Boon, B. D. C., Zhou, Z., Rozemüller, A. J. M., Bouwman, F. H., Schoonheim, M. M., van de Berg, W. D. J., & Jonkman, L. E. (2022) · Brain · doi:10.1093/brain/awac093 · Cited by 47
“76 – 79 In our results, we found that reduced parahippo-campal tract integrity associated with increased amyloid-β burden, and higher CDR scores in Alzheimer ’ s disease donors.”
Shah, P., Lal, N., Leung, E., Traul, D., Gonzalo‐Ruiz, A., & Geula, C. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090937 · Cited by 50
“This observation is consistent with the general disruption of the neuropil attributed to plaques.34 The basal forebrain cholinergic system, including its cortically projecting axons, is subject to early pathology and damage in the course of normal aging and in AD.36 Our observations suggest that fA in plaques may cont…”
BackgroundInfluentialCangalaya, C., Wegmann, S., Sun, W., Diez, L., Gottfried, A., Richter, K., Stoyanov, S., Pakan, J. M. P., Fischer, K., & Dityatev, A. E. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.02.023 · Cited by 49
Lord, A., Philipson, O., Klingstedt, T., Westermark, G. T., Hammarström, P., Nilsson, K. P. R., & Nilsson, L. N. G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.052 · Cited by 46
“Consistent with this hypothesis, rapid formation of compact plaques has been demonstrated in transgenic models, which are known to develop few diffuse A deposits.(44,45) A begins to accumulate inside neurons.”
BackgroundNanoimaging for protein misfolding diseases
Lyubchenko, Y. L., Kim, B., Krasnoslobodtsev, A. V., & Yu, J. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.102 · Cited by 51
Topological analyses in APP/PS1 mice reveal that astrocytes do not migrate to amyloid-β plaques
Galea, E., Morrison, W., Hudry, E., Arbel-Ornath, M., Bacskai, B. J., Gómez-Isla, T., Stanley, H. E., & Hyman, B. T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516779112 · Cited by 44
Self-citationOligodendrocytes are a Novel Source of Amyloid Peptide Generation
Skaper, S. D., Evans, N. A., Soden, P. E., Rosin, C., Facci, L., & Richardson, J. C. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0022-9 · Cited by 43
“In addition, early in the disease microplaques can damage neighbouring axons and dendrites within days [ 8 ].”
BackgroundMorphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
Almeida, Z. L., Vaz, D. C., & Brito, R. M. M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04543-4 · Cited by 52
P2Y receptors in Alzheimer's disease
Erb, L., Cao, C., Ajit, D., & Weisman, G. A. (2015) · Biology of the Cell · doi:10.1111/boc.201400043 · Cited by 43
“…thought to play a neuroprotective role in AD by migrating towards Aβ plaques (Perlmutter et al., 1990; Frautschy et al., 1998; Bolmont et al., 2008; Meyer-Luehmann et al., 2008; Zheng et al., 2010) and clearing neurotoxic Aβ by endocytosis (Shie et al., 2005; Bolmont et al., 2008; Kim et al.,…”
BackgroundVascular damage: A persisting pathology common to Alzheimer’s disease and traumatic brain injury
Franzblau, M., Gonzales-Portillo, C., Gonzales-Portillo, G. S., Diamandis, T., Borlongan, M. C., Tajiri, N., & Borlongan, C. V. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.09.012 · Cited by 45
“TBI has been found to increase Ab secretion in the brain [34] and, as discussed previously, the accumulation of Ab in the brain can trigger AD [35].”
Collins, J. M., King, A. E., Woodhouse, A., Kirkcaldie, M. T. K., & Vickers, J. C. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.034 · Cited by 43
Zhang, L., Ma, L., Zhang, L., Dai, J., Chang, L., Huang, P., & Tian, X. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.169105 · Cited by 43
“It is widely accepted that the extracellular accumulation of Aβ in senile plaques is an important event in the pathogenesis of AD.”
BackgroundInfluentialLiu, P., Reichl, J. H., Rao, E. R., McNellis, B. M., Huang, E. S., Hemmy, L. S., Forster, C. L., Kuskowski, M. A., Borchelt, D., Vassar, R. J., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-161027 · Cited by 45
Wang, S., Lin, Y., Todorova, N., Xu, Y., Mazo, M. M., Rana, S., Leonardo, V., Amdursky, N., Spicer, C. D., Alexander, B. D., et al. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b04144 · Cited by 47
Brain Disorders and Chemical Pollutants: A Gap Junction Link?
Mesnil, M., Defamie, N., Naus, C. C. G., & Sarrouilhe, D. (2020) · Biomolecules · doi:10.3390/biom11010051 · Cited by 52
“Such activation leads to ATP and glutamate release with neurotoxic effects [443,444,503].”
BackgroundAptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases
Murakami, K., Izuo, N., & Bitan, G. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101478 · Cited by 45
“In this context, it is important to consider, however, that fibrils might sequester the more toxic Aβ oligomers and possibly are a way cells attempt to reduce the damage caused by the oligomers (23).”
BackgroundCalcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production
Lovell, M. A., Abner, E., Kryscio, R., Xu, L., Fister, S. X., & Lynn, B. C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/787805 · Cited by 43
Lyons, B., Friedrich, M. G., Raftery, M. J., & Truscott, R. J. W. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03891 · Cited by 46
Ren, X., Yao, L., Wang, Y., Mei, L., & Xiong, W.-C. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02422-0 · Cited by 42
Listening to the Brain With Photoacoustics
Hu, S. (2015) · IEEE Journal of Selected Topics in Quantum Electronics · doi:10.1109/jstqe.2015.2487890 · Cited by 41
“through different types of invasive cranial windows have shown evident inconsistency [58]–[60], underscoring the importance of Aβ imaging through the intact mouse skull.”
BackgroundAβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology
Friesen, M., & Meyer‐Luehmann, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00233 · Cited by 44
Self-citationJolivel, V., Brun, S., Binamé, F., Benyounes, J., Taleb, O., Bagnard, D., Seze, J. D., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2021) · Cells · doi:10.3390/cells10030698 · Cited by 47
“For instance, they migrate in the direction of a forebrain stab lesion [52] or towards newly forming plaques in an animal model of Alzheimer’s disease [53].”
BackgroundNLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 38
“Among inflammasomes, NLRP3 is the most studied and characterized, and its activation in neurodegenerative diseases mainly focuses on astrocytes and microglia [50].”
BackgroundRamos‐Rodríguez, J. J., Infante‐Garcia, C., Galindo-Gonzalez, L., Garcia-Molina, Y., Lechuga-Sancho, A. M., & García-Alloza, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9311-2 · Cited by 47
“571), supporting the idea that SP size is stable once deposited [17, 22].”
BackgroundThe Inside-Out Amyloid Hypothesis and Synapse Pathology in Alzheimer's Disease
Gouras, G. K., Willén, K., & Faideau, M. (2014) · Neurodegenerative Diseases · doi:10.1159/000354776 · Cited by 42
Fibrillar Amyloid Plaque Formation Precedes Microglial Activation
Jung, C. K. E., Keppler, K., Steinbach, S., Blazquez-Llorca, L., & Herms, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119768 · Cited by 42
“In a more detailed description, we therefore herewith confirm the original finding by Meyer-Luehmann and colleagues that the formation of amyloid plaques precedes the recruitment of microglia ([21]).”
ResultKaminski, C. F., & Schierle, G. S. K. (2016) · Neurophotonics · doi:10.1117/1.nph.3.4.041807 · Cited by 45
“Fusion protein technology permits imaging directly at the live cell, or even organism, level.(17,18) This opens a whole range of possibilities for functional imaging techniques, so-called multiparameter imaging techniques, that report on molecular selfassembly directly in aggregation models of patho-biological relevan…”
BackgroundKokjohn, T., & Roher, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787847315 · Cited by 42
Calmodulin antagonizes amyloid-β peptides-mediated inhibition of brain plasma membrane Ca2+-ATPase
Berrocal, M., Sepúlveda, M. R., Vázquez-Hernández, M., & Mata, A. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.013 · Cited by 45
Ellis, B., Hye, A., & Snowden, S. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141899 · Cited by 40
The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy
Cisternas, P., Taylor, X., & Lasagna‐Reeves, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246319 · Cited by 44
“In AD patients and AD mouse models, microglia clusters around plaques and vascular amyloid, moving toward newly formed plaques within 24 h of their formation as well as toward existing plaques [136,137], displaying an activated phenotype capable of producing cytokines and chemokines such as IL-1, IL-6, TNF-α, TGF-β1,…”
BackgroundFang, Y., Yao, L., Li, C., Wang, J., Wang, J., Chen, S., Zhou, X.-F., & Liao, H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0522-x · Cited by 41
Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond
Agyemang, A. F., Harrison, S. R., Siegel, R. M., & McDermott, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0496-2 · Cited by 43
Lou, G., ZHANG, Q.-H., Xiao, F., Xiang, Q., Su, Z., Zhang, L., Yang, P., Yang, Y. F., Zheng, Q., & Huang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.003 · Cited by 43
Kojro, E., & Postina, R. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0998 · Cited by 43
Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice
García-Alloza, M., Borrelli, L. A., Hyman, B. T., & Bacskai, B. J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.006 · Cited by 48
“In this sense, previous studies have shown that senile plaques are a source of focal neurotoxicity in AD and in transgenic mice (Bolmont et al., 2007; Meyer-Luehmann et al., 2008; Urbanc et al., 2002).”
BackgroundMethodResultSelf-citationYue, F., Feng, S., Lu, C., Zhang, T., Tao, G., Liu, J., Yue, C., & Jing, N. (2021) · iScience · doi:10.1016/j.isci.2021.103207 · Cited by 44
Maesako, M., Uemura, K., Iwata, A., Kubota, M., Watanabe, K., Uemura, M., Noda, Y., Asada-Utsugi, M., Kihara, T., Takahashi, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072796 · Cited by 39
Rodriguez, J. J., Noristani, H. N., & Verkhratsky, A. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0693-5 · Cited by 39
“2008) and APPswe/PS1d99YFP mice (Meyer-Luehmann et al. 2008).”
Clustering of plaques contributes to plaque growth in a mouse model of Alzheimer’s disease
McCarter, J. F., Liebscher, S., Bachhuber, T., Abou-Ajram, C., Hübener, M., Hyman, B. T., Haass, C., & Meyer-Luehmann, M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1137-2 · Cited by 39
“Another explanation for less close new plaques in animals with higher plaque density could be microglia that are recruited to the plaques [24] and take up Aβ material [6].”
BackgroundResultInfluentialSelf-citationRonco, C., Carletti, E., Colletier, J., Weik, M., Nachon, F., Jean, L., & Renard, P. (2011) · ChemMedChem · doi:10.1002/cmdc.201100438 · Cited by 43
Metadata
- Authors
- Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7179
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3264491
- OpenAlex
- W2107015337
- Cited by
- 987
- References
- 27
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 45 · 2023: 38 · 2022: 45 · 2021: 56 · 2020: 43 · 2019: 40 · 2018: 37 · 2017: 36 · 2016: 57 · 2015: 51 · 2014: 48 · 2013: 62 · 2012: 83
- FWCI
- 66.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R01AG008487, P50AG005134, P30AG062421)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid plaques, microglial activation, microglial recruitment, APP/PS1 mice, amyloid hypothesis, cortical degeneration
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Transgenic, Time Factors, Amyloid beta-Peptides, Neurites, Microglia, Disease Progression, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.